PacBio Raises $109M in Series F Financing Round; Wins NHGRI Grant for Direct Transcriptome Sequencing | GenomeWeb

By Julia Karow

This article was originally published July 14.

Pacific Biosciences said last week that it has raised $109 million in a Series F round of financing, bringing its total capital raised to date to approximately $370 million. Also, the company last month won a two-year grant from the National Human Genome Research Institute, worth $971,000 in fiscal year 2010, to develop direct transcriptome sequencing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.